Flu vaccine racket  Swine flu vaccine  Mercury

Mercury in 4 AH1N1 U.S. injectable vaccines: Fluarix, FLULAVAL, FLUVIRIN, Fluzone

http://www.vaccinesafety.edu/package_inserts.htm

 Influenza A (H1N1) 2009 Monovalent Vaccine
Manufactured by CSL Limited
Suspension for Intramuscular Injection
Initial U.S. Approval: 2007

Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg HA per 0.5 mL dose of influenza A/California/7/2009 (H1N1)v-like virus.
The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.

A single 0.5 mL dose of Influenza A (H1N1) 2009 Monovalent Vaccine contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate (. 10 ppm), ovalbumin (. 1 mcg), neomycin sulfate (. 0.2 picograms [pg]), polymyxin B (. 0.03 pg), and beta-propiolactone (< 25 nanograms).
The rubber tip cap and plunger used for the preservative-free, single-dose syringes and the rubber stoppers used for the multi-dose vial contain no latex.



 Influenza A (H1N1) 2009 Monovalent Vaccine
Manufactured by Novartis Vaccines and Diagnostics Ltd.
Suspension for Intramuscular Injection

 DOSAGE FORMS AND STRENGTHS
Influenza A (H1N1) 2009 Monovalent Vaccine, a sterile suspension for intramuscular injection, is supplied in two presentations:
Prefilled single dose syringe, 0.5-mL. Thimerosal, a mercury derivative used during manufacture, is removed by subsequent purification steps to a trace amount (. 1 mcg mercury per 0.5-mL dose) (3, 11)
Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury per 0.5-mL dose). Thimerosal is added as preservative. (3,11)



 sanofi pasteur 10 September 2009_v0.3 449/454 Influenza A (H1N1) 2009 Monovalent Vaccine

. DOSAGE FORMS AND STRENGTHS 4

Influenza A (H1N1) 2009 Monovalent Vaccine is a sterile suspension for intramuscular injection. [See Description (11)]
Influenza A (H1N1) 2009 Monovalent Vaccine is supplied in 4 presentations:
) Prefilled syringe, 0.25 mL, no preservative, for 6 through 35 months of age; distinguished by 9 a pink syringe plunger rod;
) Prefilled syringe, 0.5 mL, no preservative, for 36 months of age and older; 11
) Single-dose vial, 0.5 mL, no preservative, for 36 months of age and older; 12
) Multi-dose vial, 5 mL, for 6 months of age and older, contains thimerosal, a mercury 13 derivative, added as a preservative. Each 0.5 mL dose contains 25 micrograms (mcg) mercury.
 

http://www.vaccinesafety.edu/package_inserts.htm

 http://us.gsk.com/products/assets/us_fluarix.pdf
GSK Fluarix
DESCRIPTION
FLUARIX, Influenza Virus Vaccine, for intramuscular injection, is a sterile colorless to slightly opalescent suspension. FLUARIX is a vaccine prepared from influenza viruses propagated in embryonated chicken eggs. Each of the influenza viruses is produced and purified separately. After harvesting the virus-containing fluids, each influenza virus is concentrated and purified by zonal centrifugation using a linear sucrose density gradient solution containing detergent to disrupt the viruses. Following dilution, the vaccine is further purified by diafiltration. Each influenza virus solution is inactivated by the consecutive effects of sodium deoxycholate and formaldehyde leading to the production of a “split virus.” Each split inactivated virus is then suspended in sodium phosphate-buffered isotonic sodium chloride solution. The vaccine is formulated from the 3 split inactivated virus solutions.
FLUARIX has been standardized according to USPHS requirements for the 2009-2010 influenza season and is formulated to contain 45 micrograms (mcg) hemagglutinin (HA) per 0.5-mL dose, in the recommended ratio of 15 mcg HA of each of the following 3 strains: A/Brisbane/59/2007, IVR-148 (H1N1), A/Uruguay/716/2007, NYMC X-175C (H3N2) (an A/Brisbane/10/2007-like virus), and B/Brisbane/60/2008.
FLUARIX is formulated without preservatives. FLUARIX does not contain thimerosal. Each 0.5-mL dose also contains octoxynol-10 (TRITON® X-100) .0.085 mg, á-tocopheryl hydrogen succinate .0.1 mg, and polysorbate 80 (Tween 80) .0.415 mg. Each dose may also contain residual amounts of hydrocortisone .0.0016 mcg, gentamicin sulfate .0.15 mcg, ovalbumin .1 mcg, formaldehyde .50 mcg, and sodium deoxycholate .50 mcg from the manufacturing process.
The tip cap and the rubber plunger of the needleless prefilled syringes contain dry natural latex rubber.


GSK Flulaval
http://us.gsk.com/products/assets/us_flulaval.pdf


 DOSAGE FORMS AND STRENGTHS--------------
• FLULAVAL is a suspension in 5-mL multi-dose vials containing 10 doses (each dose is 0.5 mL). (3)
• Each 0.5-mL dose contains 15 micrograms (mcg) of influenza virus hemagglutinin (HA) of each of the following 3 strains: A/Brisbane/59/2007, IVR-148 (H1N1), A/Uruguay/716/2007, NYMC X-175C (H3N2) (an A/Brisbane/10/2007-like virus), and B/Brisbane/60/2008. (3, 11)
• Thimerosal, a mercury derivative, is added as a preservative. Each 0.5 mL dose contains 25 mcg mercury. (3)

Novartis Fluvirin

http://www.novartisvaccines.com/us/downloads/Fluvirin_PI_2009_2010.pdf

 DOSAGE FORMS AND STRENGTHS
FLUVIRIN®, a sterile suspension for intramuscular injection, is supplied in two presentations:
Prefilled syringe, 0.5-mL. Thimerosal, a mercury derivative used during manufacture, is removed by subsequent purification steps to a trace amount (. 1 mcg mercury per 0.5-mL dose). (3, 11)
Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury per 0.5-mL dose). Thimerosal is added as a preservative. (3,11)


https://www.vaccineshoppe.com/image.cfm?doc_id=10913&image_type=product_pdf
Sanofi Pasteur - Fluzone

DOSAGE FORMS AND STRENGTHS
Fluzone, a sterile suspension for intramuscular injection, is supplied in four
presentations:
• Prefilled syringe, 0.25 mL, no preservative, pediatric dose, distinguished
by a pink syringe plunger rod (3)
• Prefilled syringe, 0.5 mL, no preservative (3)
• Single-dose vial, 0.5 mL, no preservative (3)
• Multi-dose vial, 5 mL, contains thimerosal, a mercury derivative, added as
a preservative. Each 0.5 mL dose contains 25 mcg mercury. (3)